Dr. Zirwas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Bexley Dermatology - DGC
2359 East Main Street
Bexley, OH 43209Phone+1 614-947-1716
Education & Training
- UPMC Medical EducationResidency, Dermatology, 2001 - 2004
- UPMC Medical EducationInternship, Internal Medicine, 2000 - 2001
- University of Pittsburgh School of MedicineClass of 2000
Certifications & Licensure
- OH State Medical License 2004 - 2025
- TN State Medical License 2019 - 2022
- SC State Medical License 2012 - 2017
- TX State Medical License 2012 - 2012
- PA State Medical License 2001 - 2006
- American Board of Dermatology Dermatology
Clinical Trials
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment Start of enrollment: 2023 Nov 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- Patient and Healthcare Provider Perspectives on the Pathway to Diagnosis of Seborrheic Dermatitis in the United States.Raj Chovatiya, Meredith T Polaskey, Lakshi Aldredge, Candrice Heath, Moises Acevedo
Advances in Therapy. 2024-12-01 - 3 citationsEfficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial ...Brett King, Maryanne M Senna, Natasha A Mesinkovska, Charles Lynde, Matthew Zirwas
Journal of the American Academy of Dermatology. 2024-11-01 - Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National Survey.Meredith T Polaskey, Lakshi Aldredge, Candrice Heath, Moises Acevedo, David H Chu
Dermatology and Therapy. 2024-11-01
Press Mentions
- Challenging Cases in Atopic DermatitisDecember 7th, 2022
- What Patients Need to Know About New JAK Topical Inhibitor - Dermatology Times October 2nd, 2021
- Clinical Challenges: Chronic Itch in Atopic DermatitisAugust 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: